Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Mayo Clinic
Mayo Clinic
University of Washington
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Yale University
National Cancer Institute (NCI)
University of Washington
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
Canadian Cancer Trials Group
University of Washington
The Lymphoma Academic Research Organisation
St. Jude Children's Research Hospital
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
Ohio State University Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
University of Washington
The Lymphoma Academic Research Organisation
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
Ohio State University Comprehensive Cancer Center
City of Hope Medical Center
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
University of Miami
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Weill Medical College of Cornell University
Ruijin Hospital
Sanofi
City of Hope Medical Center
Shanghai Junshi Bioscience Co., Ltd.
New York Medical College
University of Miami
City of Hope Medical Center
International Extranodal Lymphoma Study Group (IELSG)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
New York Medical College
Dana-Farber Cancer Institute
City of Hope Medical Center
City of Hope Medical Center
University of Miami
Institute of Hematology & Blood Diseases Hospital, China
Columbia University
University of Southampton